IgSF CAM

VCAM-1 (Vascular Cell Adhesion Molecule-1) Gene Expression Inhibitor - Pipeline Insight, 2019 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 22, 2019
Health, Genetics, Proteins, Branches of biology, SIGLEC, VCAM-1, Membrane proteins, Cell adhesion, Protein domains, Transmembrane receptors, Single-pass transmembrane proteins, IgSF CAM, Zaurategrast

The "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor development.
  • The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
  • The report assesses the active VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor pipeline products by developmental stage, product type, molecule type, and administration route.